Various diseases remain untreated due to lack of suitable therapeutic moiety or a suitable
drug delivery device, especially where toxicities and side effects are the primary reason for …

Epithelial cell adhesion molecule (EpCAM) functions not only in physiological processes but
also participates in the development and progression of cancer. In recent decades …

Nanoparticles exhibiting the localized surface plasmon resonance (LSPR) phenomenon are
promising tools for diagnostics and cancer treatment. Among widely used metal …

The targeted delivery of radionuclides to tumours holds great promise for diagnosis and
treatment of malignant neoplasms. The development of scaffold proteins has significantly …

The effect of enhanced permeability and retention is often not sufficient for highly effective
cancer therapy with nanoparticles, and the development of active targeted drug delivery …

Today, the production and use of various samples of recombinant protein/polypeptide toxins
is known and is actively developing. This review presents state-of-the-art in research and …

Targeted drug delivery is one of the most intriguing and challenging issues in modern
biomedicine. For active targeting, full-size IgG molecules (150 kDa) are usually used …

The use of traditional tools for the targeted delivery of nanostructures, such as antibodies,
transferrin, lectins, or aptamers, often leads to an entire range of undesirable effects. The …

Targeted nanoparticles of different origins are considered as new-generation diagnostic and
therapeutic tools. However, there are no targeted drug formulations within the composition of …

Targeted cancer therapies using immunotoxins have achieved remarkable efficacy in
hematological malignancies. However, the clinical development of immunotoxins is also …